Bliss GVS Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

605.46

598.34

636.36

465.51

441.95

Operating profit

107.17

90.16

109.20

91.46

100.17

Interest

5.81

10.06

4.32

4.19

4.56

Gross profit

134.86

130.87

137.50

104.95

130.54

EPS (Rs)

4.84

8.21

8.94

6.54

8.95

Other income

33.50

50.77

32.63

17.68

34.93

Stock adjustment

-6.36

21.24

-8.90

-8.85

2.37

Raw material

305.83

293.66

350.83

215.65

216.31

Power and fuel

-

-

-

-

-

Employee expenses

82.59

72.54

65.06

58.61

44.02

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

116.23

120.74

120.17

108.64

79.09

Provisions made

-

-

-

-

-

Depreciation

23.52

15.17

13.85

13.76

8.83

Taxation

19.61

30.21

33.74

23.69

29.38

Net profit / loss

50.64

85.48

92.66

67.50

92.33

Extra ordinary item

-41.09

-

2.75

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

10.47

10.42

10.37

10.31

10.31

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

17.70

15.07

17.16

19.65

22.66

GPM (%)

21.11

20.16

20.55

21.72

27.37

NPM (%)

7.93

13.17

13.85

13.97

19.36